Skip to content

Fresenius Vamed is a leading global provider of services for hospitals and other health care facilities. Its portfolio ranges from project development and planning to the total operational management of health care facilities and providing services to patients. Our services are aimed at various areas of health care, ranging from prevention to acute care, rehabilitation, and nursing.

Major events

The order backlog reached € 3,473 million.

Fresenius Vamed was awarded the total turnkey contract for the Wiener Neustadt regional hospital in 2021. In addition, Fresenius Vamed received orders for the construction of three turnkey general hospitals in Angola, a general hospital in Papua New Guinea, and other major orders from Austria, Germany, the United Arab Emirates, Kenya, Turkmenistan, and Guyana.

Crisis helper in overcoming the global pandemic.

Worldwide, Fresenius Vamed’s employees again demonstrated outstanding commitment in the second year of the pandemic. In the service business, Fresenius Vamed ensured uninterrupted operation of the health care facilities supported in technical management and reliable quality in high-end services. With great care in the acute, rehabilitation, nursing, and health tourism facilities, the recovery, recuperation, and safety of patients and guests was ensured. In the project business, Fresenius Vamed successfully met the COVID-19- related challenges with competence and experience and thanks to long-standing ­project partnerships.

Expansion of outpatient rehabilitation and creation of a new fully integrated health care facility.

Fresenius Vamed developed a special post-acute rehabilitation program for the follow-up treatment of COVID-19 patients. To meet the growing demand for rehabilitation, sites were expanded, and two further outpatient rehabilitation centers were opened in Austria. The Oberlaa site was upgraded to create Fresenius Vamed’s first fully integrated health care facility – from prevention and acute care to rehabilitation and nursing, as well as telemedicine service.

Comprehensive product portfolio

Service business
High-end services

Fresenius Vamed’s range of services covers all areas of technical, commercial, and infrastructural facility management as well as the highly specialized areas of medical technology management, sterile services, operational technology, and IT development. In 2021, we provided tech­nical facility management services for 840 health care facilities with 227,000 beds worldwide.

Total operational management

Fresenius Vamed is responsible for the total operational management of health care facilities, is a leading provider of rehabilitation and care in Central Europe, and builds a bridge between preventive medicine and health tourism with its spa and health resorts.

Project business

Fresenius Vamed’s project business comprises consulting on projects, project development, planning, turnkey construction, and financing management of projects. Fresenius Vamed responds flexibly to the local needs of clients, providing custom-tailored solutions all from a single source to put the project on the right track in functional, technical, and financial terms. Fresenius Vamed is a pioneer in the field of public-private partnerships (PPPPPP (public-private partnership model)Public-private partnership describes a government service or private business venture that is funded and operated through a partnership of government and one or more private-sector companies. In most cases, PPP accompanies a part-privatization of governmental services.) for hospitals and other health care facilities and is currently implementing the largest PPP project in the German health care sector.

Our success factors

  • Unique range of services
  • Extensive competencies in all health care areas
  • Leading position in the area of PPP models
  • Long-term life cycle models
  • Providing access to health care services
  • Worldwide education and training programs

Our growth drivers

  • Expansion of health care infrastructure in emerging markets
  • Outsourcing of non-medical services to private operators
  • Post-acute care business as platform for further international growth
  • Selective small and mid-sized acquisitions
  • Expanding positions in preventive medicine such as health tourism

Market dynamics

Telemedicine market in Europe is estimated to grow

19.1% p.a.

from 2020 to 2026.

Outsourcing of non-medical services provided by public institutions to private providers grew in Germany by around

40%

from 2014 to 2019.

Global preventive health care is estimated to grow

9.5% p.a.

till 2025.

Emerging markets’ share of global health expenditure will grow to

33%

by 2022.

The share of the EU population older than 80 years is projected to increase from 5.9% to

14.6%

between 2020 and 2100.

sales by region

sales by service and project business

Sales by business segment

Download(XLS, 35 KB)
€ in millions 2021 2020 Change % of total Fresenius Vamed sales
Project business 717 633 13% 31%
Service business 1,580 1,435 10% 69%

Sales by region

Download(XLS, 35 KB)
€ in millions 2021 2020 Change % of total Fresenius Vamed sales
Europe 1,923 1,815 6% 84%
Africa 173 80 116% 7%
Asia-­Pacific 119 136 -13% 5%
Latin America 82 37 122% 4%
Total 2,297 2,068 11% 100%

Order intake and order backlog for projects

Download(XLS, 35 KB)
€ in millions 2021 2020 Change
Order intake 1,290 1,010 28%
Order backlog 3,473 3,055 14%

Sources:
Telemedicine market in Europe is estimated to grow 19.1% p.a. from 2020 to 2026
Source: https://www.graphicalresearch.com/industry-insights/1476/europe-telemedicine-market

Global preventive health care is estimated to grow 9.5% p.a. till 2025
Source: World Health Organization, 2013 – 2015, www.who.org

The share of the EU population aged 80 years or older
Source: EC Europe, Eurostat, 2021

Outsourcing of non-medical services provided by public institutions to private providers in Germany.
Source: German Federal Statistical Office, 2019 data (most recent market data available refers to the year 2019 as no more recent data has been published)

Emerging markets’ share of global health expenditure will grow to 33% by 2022.
Source: https://www.ihealthcareanalyst.com/

photo credits: © Hocoma